Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors

Clinical trial NCT02988817 · COMPLETED

Trial details

NCT number: NCT02988817
Sponsor: Genmab
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Cervical Cancer Endometrial Cancer Non Small Cell Lung Cancer (NSCLC)Thyroid Cancer Melanoma Sarcoma Solid Tumors

Start date: 2016-11-23
Primary completion: 2021-11-12
Enrollment: 306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.